CN102600261A - 一种治疗咽炎的藏药 - Google Patents
一种治疗咽炎的藏药 Download PDFInfo
- Publication number
- CN102600261A CN102600261A CN2012101059319A CN201210105931A CN102600261A CN 102600261 A CN102600261 A CN 102600261A CN 2012101059319 A CN2012101059319 A CN 2012101059319A CN 201210105931 A CN201210105931 A CN 201210105931A CN 102600261 A CN102600261 A CN 102600261A
- Authority
- CN
- China
- Prior art keywords
- tibetan medicine
- group
- pharyngitis
- sore
- throat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 85
- 201000007100 Pharyngitis Diseases 0.000 title claims abstract description 82
- 229940079593 drug Drugs 0.000 claims description 14
- 240000007087 Apium graveolens Species 0.000 claims description 12
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 claims description 12
- 235000010591 Appio Nutrition 0.000 claims description 12
- 241000510672 Cuminum Species 0.000 claims description 12
- 239000008187 granular material Substances 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 9
- 239000003826 tablet Substances 0.000 claims description 7
- 239000002775 capsule Substances 0.000 claims description 6
- 239000006187 pill Substances 0.000 claims description 5
- 239000002552 dosage form Substances 0.000 claims description 3
- 206010068319 Oropharyngeal pain Diseases 0.000 abstract description 42
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 28
- 201000010099 disease Diseases 0.000 abstract description 26
- 230000008961 swelling Effects 0.000 abstract description 17
- 208000002193 Pain Diseases 0.000 abstract description 9
- 230000036407 pain Effects 0.000 abstract description 9
- 238000002360 preparation method Methods 0.000 abstract description 9
- 208000016150 acute pharyngitis Diseases 0.000 abstract description 8
- 230000006870 function Effects 0.000 abstract description 7
- 206010013952 Dysphonia Diseases 0.000 abstract description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract description 2
- 208000010473 Hoarseness Diseases 0.000 abstract description 2
- 241001303775 Phlomis Species 0.000 abstract description 2
- 241001049107 Pterocephalus hookeri Species 0.000 abstract description 2
- 244000111447 Rubus phoenicolasius Species 0.000 abstract description 2
- 235000003963 Rubus phoenicolasius Nutrition 0.000 abstract description 2
- 241001643425 Tinospora sinensis Species 0.000 abstract description 2
- 230000001154 acute effect Effects 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 210000003437 trachea Anatomy 0.000 abstract description 2
- 239000004480 active ingredient Substances 0.000 abstract 3
- 244000302413 Carum copticum Species 0.000 abstract 1
- 235000007034 Carum copticum Nutrition 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 230000003467 diminishing effect Effects 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 239000013641 positive control Substances 0.000 description 18
- 230000000694 effects Effects 0.000 description 17
- 241000283973 Oryctolagus cuniculus Species 0.000 description 16
- 210000003800 pharynx Anatomy 0.000 description 14
- 241001465754 Metazoa Species 0.000 description 13
- 210000004877 mucosa Anatomy 0.000 description 13
- 241000699670 Mus sp. Species 0.000 description 12
- 238000002156 mixing Methods 0.000 description 12
- 208000024891 symptom Diseases 0.000 description 12
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 10
- 230000001225 therapeutic effect Effects 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 206010018691 Granuloma Diseases 0.000 description 7
- 206010061218 Inflammation Diseases 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 230000035876 healing Effects 0.000 description 6
- 230000004054 inflammatory process Effects 0.000 description 6
- 231100000614 poison Toxicity 0.000 description 6
- 229960000583 acetic acid Drugs 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 5
- 238000003745 diagnosis Methods 0.000 description 5
- 239000012362 glacial acetic acid Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 238000005303 weighing Methods 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 4
- 240000001624 Espostoa lanata Species 0.000 description 4
- 235000009161 Espostoa lanata Nutrition 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 230000036760 body temperature Effects 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 238000007689 inspection Methods 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 238000012856 packing Methods 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 244000061176 Nicotiana tabacum Species 0.000 description 3
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 3
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 230000036592 analgesia Effects 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 230000002950 deficient Effects 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 239000000428 dust Substances 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000002662 enteric coated tablet Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 3
- 229960000905 indomethacin Drugs 0.000 description 3
- 206010022000 influenza Diseases 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 2
- 239000003390 Chinese drug Substances 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241001278898 Glycyrrhiza inflata Species 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 206010000269 abscess Diseases 0.000 description 2
- 229960001138 acetylsalicylic acid Drugs 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 230000004856 capillary permeability Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- -1 dry below 60 °C Substances 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 210000005069 ears Anatomy 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 208000013403 hyperactivity Diseases 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- 241000321096 Adenoides Species 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 208000031636 Body Temperature Changes Diseases 0.000 description 1
- 208000031648 Body Weight Changes Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010009152 Chronic tonsillitis Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241000125183 Crithmum maritimum Species 0.000 description 1
- 244000304337 Cuminum cyminum Species 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- 208000019505 Deglutition disease Diseases 0.000 description 1
- 241000555268 Dendroides Species 0.000 description 1
- 241000123586 Dipsacaceae Species 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 239000001828 Gelatine Substances 0.000 description 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 description 1
- 241000701044 Human gammaherpesvirus 4 Species 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 241000581650 Ivesia Species 0.000 description 1
- 241001582888 Lobus Species 0.000 description 1
- 241000218164 Menispermaceae Species 0.000 description 1
- 208000001705 Mouth breathing Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 241000202934 Mycoplasma pneumoniae Species 0.000 description 1
- 206010033425 Pain in extremity Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 240000003428 Tinospora crispa Species 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 230000006022 acute inflammation Effects 0.000 description 1
- 210000002534 adenoid Anatomy 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000009285 allergic inflammation Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000001949 anaesthesia Methods 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000000146 antalgic effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000004579 body weight change Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 208000037893 chronic inflammatory disorder Diseases 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000001524 infective effect Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 210000002741 palatine tonsil Anatomy 0.000 description 1
- 230000001314 paroxysmal effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000011555 rabbit model Methods 0.000 description 1
- 238000011552 rat model Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 238000007560 sedimentation technique Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000008925 spontaneous activity Effects 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210105931 CN102600261B (zh) | 2012-04-12 | 2012-04-12 | 一种治疗咽炎的藏药 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210105931 CN102600261B (zh) | 2012-04-12 | 2012-04-12 | 一种治疗咽炎的藏药 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102600261A true CN102600261A (zh) | 2012-07-25 |
CN102600261B CN102600261B (zh) | 2013-08-07 |
Family
ID=46518280
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201210105931 Active CN102600261B (zh) | 2012-04-12 | 2012-04-12 | 一种治疗咽炎的藏药 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102600261B (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060257507A1 (en) * | 2002-06-06 | 2006-11-16 | J.B. Chemicals & Pharmaceuticals, Ltd. | Herbal cough formulations and process for the preparation thereof |
CN101024663A (zh) * | 2007-04-09 | 2007-08-29 | 中国药品生物制品标准化研究中心 | 一种新化合物、含有该化合物的提取物及制备方法和应用 |
CN101647993A (zh) * | 2009-07-20 | 2010-02-17 | 甘肃奇正藏药有限公司 | 一种用于治疗流行性感冒的药物及其制备和检测方法 |
-
2012
- 2012-04-12 CN CN 201210105931 patent/CN102600261B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060257507A1 (en) * | 2002-06-06 | 2006-11-16 | J.B. Chemicals & Pharmaceuticals, Ltd. | Herbal cough formulations and process for the preparation thereof |
CN101024663A (zh) * | 2007-04-09 | 2007-08-29 | 中国药品生物制品标准化研究中心 | 一种新化合物、含有该化合物的提取物及制备方法和应用 |
CN101647993A (zh) * | 2009-07-20 | 2010-02-17 | 甘肃奇正藏药有限公司 | 一种用于治疗流行性感冒的药物及其制备和检测方法 |
Non-Patent Citations (1)
Title |
---|
曾宪荣,等: "《三十年文集(1961-1991)》", 31 July 1991, article "藏药催汤丸对流感病毒的抑制观察", pages: 552 * |
Also Published As
Publication number | Publication date |
---|---|
CN102600261B (zh) | 2013-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101549101B (zh) | 一种用于治疗尘肺病和耐药性肺结核病的中药及制备方法 | |
CN101711830B (zh) | 一种治疗慢性支气管炎的中药组合物 | |
CN103157030B (zh) | 一种治疗小儿感冒后咳嗽的中药组合物 | |
CN103301271B (zh) | 一种治疗咽炎的藏药及其制备方法 | |
CN104324125B (zh) | 一种治疗慢性咽炎的中药组合物及其制备方法 | |
CN104940485A (zh) | 一种治疗小儿哮喘的中药组合物及其制备方法 | |
CN102614269A (zh) | 一种治疗咽炎藏药的制备方法 | |
CN104208473A (zh) | 一种治疗风热型咳喘疾病的中药组合物及其用途 | |
CN103705890A (zh) | 一种具有清肺止咳作用的药物组合物 | |
CN105497723A (zh) | 一种治疗细菌性肺炎的中药制剂及其制备方法 | |
CN102526236B (zh) | 一种治疗流行性感冒的药物及其制备方法 | |
CN103990061A (zh) | 一种治疗肺热咳嗽的中药组合物 | |
CN103861041B (zh) | 一种治疗急慢性鼻炎的中药组合物及其制备方法 | |
CN103977270B (zh) | 一种治便秘的中药 | |
CN102526488B (zh) | 一种具有清咽功能的中药组合物 | |
CN101804149B (zh) | 一种治疗咽喉炎的中药 | |
CN105125838A (zh) | 一种治疗小儿哮喘的中药组合物及其制备方法 | |
CN105056046A (zh) | 一种治疗感冒咳嗽的中药口服液及制备方法 | |
CN102600261A (zh) | 一种治疗咽炎的藏药 | |
CN1679882A (zh) | 一种治疗咳喘症的中药制剂及其制备方法 | |
CN103494924B (zh) | 一种治疗湿热郁结型痤疮的中药组合物 | |
CN103463537B (zh) | 治疗小儿哮喘的药物 | |
CN104353053A (zh) | 一种用于治疗猪支原体肺炎的中药组合物及其制备方法 | |
CN105168860A (zh) | 一种治疗小儿哮喘的中药组合物及其制备方法 | |
CN104623203A (zh) | 一种治疗血虚风燥型湿疹的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20161009 Address after: 810000 Xining biological science and Technology Industrial Park, No. three, No. 18, Qinghai Patentee after: Qinghai Jiumei Zang Drug Drug Co.,Ltd. Address before: 810003, 18, No. three, Biotechnology Industrial Park, Chengbei District, Qinghai, Xining Patentee before: Jiumei Pengcuo |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Tibetan medicine for treating pharyngitis and preparation method thereof Effective date of registration: 20200525 Granted publication date: 20130807 Pledgee: Qinghai Chuangqi Finance Leasing Co.,Ltd. Pledgor: Qinghai Jiumei Zang Drug Drug Co.,Ltd. Registration number: Y2020630000001 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20210517 Granted publication date: 20130807 Pledgee: Qinghai Chuangqi Finance Leasing Co.,Ltd. Pledgor: Qinghai Jiumei Zang Drug Drug Co.,Ltd. Registration number: Y2020630000001 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A Tibetan medicine for pharyngitis Effective date of registration: 20210602 Granted publication date: 20130807 Pledgee: Qinghai Chuangqi Finance Leasing Co.,Ltd. Pledgor: Qinghai Jiumei Zang Drug Drug Co.,Ltd. Registration number: Y2021630000003 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230608 Granted publication date: 20130807 Pledgee: Qinghai Chuangqi Finance Leasing Co.,Ltd. Pledgor: Jiumei Pengcuo|Qinghai Jiumei Zang Drug Drug Co.,Ltd. Registration number: Y2021630000003 |